Answers are grounded in this paper and cite their sources.
BayesReact uncovers microRNA activity across cancers and tissues, indicating novel regulatory insights.
Gene regulatory mechanisms control cell differentiation and homeostasis but are often undetectable, particularly at the single-cell level. We introduce bayesReact, which quantifies regulatory activities from bulk or single-cell omics data. It is based on an unsupervised generative model, exploiting the fact that each regulator typically targets many genes sharing a sequence motif. Using mRNA expression data, we illustrate and evaluate bayesReact on microRNAs (miRNAs). It outperforms existing methods on sparse bulk data and improves activity inference on single-cell data. Inferred miRNA activities correlate with miRNA expression across pan-cancer TCGA and healthy GTEx tissue samples. The activities capture cancer-type-specific miRNA patterns, e.g., for miR-122-5p and miR-124-3p, which also correlate more strongly with their target genes than their measured expression. This includes a strong negative correlation between miR-124-3p and the anti-neuronal REST transcription factor in nervous system cancers. Analyzing single-cell data, bayesReact detects prominent miRNAs during murine stem cell differentiation, including miR-298-5p, miR-92-2-5p, and the Sfmbt2 cluster (miR-297-669). Furthermore, spatio-temporal inference shows increasing miR-124-3p activity in differentiating neurons during embryonic spinal cord development in mice. bayesReact enables large-scale hypothesis-generating screens for novel regulatory factors and the discovery of condition-specific activities. It is implemented as a user-friendly R package (https://github.com/JakobSkouPedersenLab/bayesReact).
No takes yet. Share an insight, caveat, or question.
Rasmussen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: